Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, active-controlled, phase III clinical trial to
investigate the efficacy and safety of evogliptin when added to ongoing metformin monotherapy
in patients with type 2 diabetes who have inadequate glycemic control